PMCAN for Smokers at Smoking Hotspots
Proactive Minimal Cessation Advice Plus Nicotine Replacement Therapy (PMCAN) for Smoking Cessation in Smokers at Smoking Hotspots: a Pilot Randomized Controlled Trial
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
Background: Many smokers cannot quit due to nicotine withdrawal symptoms, which peak at the first week of abstinence. Proactive recruitment of smokers is needed as most smokers do not seek smoking cessation (SC) services. A smoking hotspot (SH) is defined as a public outdoor place where smokers stop/linger and smoke. We aim to include a reasonably "representative" or unbiased sample of SH at different locations from all 3 regions of Hong Kong. We will randomly select 6 eligible SH (2 in each regions) from the 15 hotspots in our previous community trial. Methods: Two trained SC ambassadors (student helpers) and one supervisor (experienced research assistant) will be deployed for each session of intervention at a SH. Potential subjects will be approached using the "a-foot-into-the-door" method in which SC ambassador will ask if smoker would like to reduce/quit smoking and receive SC intervention or advices. Smokers will be assessed for eligibility and informed written consent will be sought. Subjects will complete a brief self-administered questionnaire (baseline) using tablet. To reduce later hang-ups of telephone interventions or surveys, SC ambassador will save contact number of the trial into subjects' mobile phones. Discussion: The findings will provide much needed and original evidence to support a main RCT on these new, proactive, simple and low-cost interventions for improving current SC services and policy for smokers who do not actively seek help from SC services in Hong Kong and elsewhere.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 12, 2016
CompletedFirst Posted
Study publicly available on registry
October 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2016
CompletedSeptember 25, 2019
September 1, 2019
3 months
October 12, 2016
September 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exhaled CO validated abstinence
3 month
Secondary Outcomes (3)
Self-reported past 7-day point prevalence abstinence
3 month
Nicotine Replacement Therapy use
3 month
Smoking cessation service use
3 month
Study Arms (4)
Nicotine Replacement Therapy
EXPERIMENTALThis experimental group receives health warning leaflet, 1-week free nicotine replacement therapy (gum/patch), a card containing instruction and potential side effects and follow-up intervention if they have the above side effects at 3-, 7- and 10-days.
Minimal Cessation Advice & Nicotine Replacement Therapy
EXPERIMENTALThis experimental group receives brief smoking cessation advice using AWARD model with a health warning leaflet, 1-week free nicotine replacement therapy (gum/patch), a card containing instruction and potential side effects and follow-up intervention if they have the above side effects at 3-, 7- and 10-days.
Minimal Cessation Advice
EXPERIMENTALThis experimental group receives brief smoking cessation advice using AWARD model with a health warning leaflet.
Control
ACTIVE COMPARATORThis control group receives a health warning leaflet.
Interventions
1-week free NRT (gum/patch) plus a card containing instruction and potential side effects.
Brief smoking cessation advice using AWARD model. AWARD: (1) Ask smoking habit; (2) Warn about smoking risk; (3) Advice to quit as soon as possible; (4) Refer to smoking cessation service; and (5) Do-it-again: if relapse/fail.
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Eligibility Criteria
You may qualify if:
- Adult smokers aged 18+ who smoke cigarettes daily.
- Exhaled carbon monoxide (CO) level of 4ppm or above.
- Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua)
You may not qualify if:
- Smokers who have contraindication for NRT use: severe angina, arrhythmia, myocardia infraction, pregnancy (or intended to become pregnant \<6 months) or breastfeeding.
- Smokers who have psychiatric/psychological diseases or regular psychotropic medications
- Smokers who are using SC medication, NRT, other SC services or projects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Man Ping WANG
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 12, 2016
First Posted
October 17, 2016
Study Start
September 1, 2016
Primary Completion
November 30, 2016
Study Completion
November 30, 2016
Last Updated
September 25, 2019
Record last verified: 2019-09